Upstream Manufacturing Webinars

  1. Where Does Upstream End And Downstream Begin? 3/9/2026

    In this opening segment from the Bioprocess Online Live event, “Optimizing Process Development Through Upstream And Downstream Integration,” our panel of process development experts weighs in on where exactly to draw the line between upstream and downstream development.

  2. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

    Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

  3. Krakatoa® K500: A Seismic Shift In Media And Buffer Consumption 2/24/2026

    Learn how point-of-use media manufacturing delivers 30-50% cost savings while eliminating cold chain logistics, improving consistency, and accelerating advanced therapy production timelines.

  4. Steady & Stable From Lab To Launch: Seamless Scale-Up With The First And Only GMP Transfection Stabilizer 2/24/2026

    Learn how extended transfection stability windows and reduced complex volumes solve critical scale-up challenges in AAV and lentivirus manufacturing at 1000+ liter production scales.

  5. A Faster, More Sensitive Approach To Virus Detection 2/13/2026

    Discover a faster, more sensitive approach to rodent virus detection that offers a targeted NGS workflow to help uncover contaminants traditional assays may miss.

  6. Flexibility Or Scale? Navigating The Single Use Vs. Stainless Steel Debate 2/12/2026

    Explore how to choose between single‑use and stainless‑steel bioreactors, outlining key advantages, limitations, and long‑term considerations essential for successful biologics scale‑up.

  7. Simplified Harvest And Media Exchange In Cell Therapy 1/28/2026

    Scale-up often introduces shear stress and process variability. Learn how low-shear, single-use technology stabilizes media exchange and harvest, ensuring consistent cell quality and predictable performance.

  8. Next-Level Cell Lines: An Integrated Approach To Biologic Innovation 1/22/2026

    See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.

  9. Overcoming Regulatory Hurdles In AAV Production 12/16/2025

    Demonstrating residual reagent clearance is a critical regulatory requirement in AAV manufacturing. Explore how specialized assays and strategic partnerships streamline compliance.

  10. From Lab To Commercialization: Simplifying Bioprocess Scale-Up 12/16/2025

    Explore how unique cuboid geometries and advanced mixing dynamics create consistent performance from the bench to commercial manufacturing, ensuring flexibility and improved productivity.